Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
7
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
celgene
7
×
detroit blog main
detroit top stories
fda
7
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
bristol-myers squibb
clinical trials
eli lilly
ipo
merck
pfizer
abbvie
astrazeneca
gene therapy
johnson & johnson
medical devices
What
bio
roundup
ipo
celgene
companies
days
fda
life
news
science
week
airport
allogene
annual
apocalypse
approved
arena’s
august
beds
biopharma
biotech
biotechs
bounty
busy
cancer
car
chose
cig
close
colleagues
comeback
company
corner
crispr
deals
decisions
delivered
device
devices
digital
Language
unset
Current search:
celgene
×
fda
×
biotech
×
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way